Utah Medical Products, Inc. Announces Quarterly Dividend
Rhea-AI Summary
Utah Medical Products (Nasdaq: UTMD) announced a quarterly cash dividend of $0.31 per share, payable on July 3, 2026 to shareholders of record at the close of business on June 17, 2026. This reflects a 1.6% increase versus the same quarter last year.
The company develops and sells disposable and reusable specialty medical devices focused on maternal and neonatal care in over 100 countries. For more information, visit UTMD's website.
Positive
- None.
Negative
- None.
News Market Reaction – UTMD
In the May 5 session, UTMD gained 0.32%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, UT / ACCESS Newswire / May 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on July 3, 2026 to stockholders of record at the close of business on June 17, 2026. This is a
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
Contact:
Brian Koopman
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View the original press release on ACCESS Newswire